文献速递甲状腺疾病

身高、自身免疫性甲状腺疾病与甲状腺癌:一项孟德尔随机化研究

Height, Autoimmune Thyroid Disease, and Thyroid Cancer: A Mendelian Randomization Study.
PubMed 文献 · Thyroid · 2023-10-26

结果显示,遗传预测身高每增加1个标准差,AITD风险增加4%(CI 1.02至1.07,p值=1.99E-03),甲状腺癌风险增加15%(CI 1.07至1.23,p值=2.32E-04);双向孟德尔随机化未发现AITD与成年身高存在因果关联。

要点

  • 遗传预测身高每增加1个标准差,AITD风险增加4%(CI 1.02至1.07,p值=1.99E-03)。
  • 遗传预测身高每增加1个标准差,甲状腺癌风险增加15%(CI 1.07至1.23,p值=2.32E-04)。
  • 双向孟德尔随机化未发现AITD与成年身高之间存在因果关联。

核心结论

  • 遗传预测身高每增加1个标准差与AITD和甲状腺癌风险增加相关;未发现遗传预测AITD与身高存在因果关联的证据。

研究设计与样本

  • AITD和甲状腺癌的汇总数据来自大规模全基因组关联研究,分别包含30,234例和3001例病例。
  • 采用双向孟德尔随机化检验AITD与成年身高之间的反向因果关联。

主要发现

  • 遗传预测身高每增加1个标准差,AITD风险增加4%(CI 1.02至1.07,p值=1.99E-03)。
  • 遗传预测身高每增加1个标准差,甲状腺癌风险增加15%(CI 1.07至1.23,p值=2.32E-04)。
  • 双向孟德尔随机化未显示AITD与成年身高之间存在任何因果关联。
  • 敏感性分析证实了主要结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Increased height has been associated with increased risk of hypothyroidism or thyroid cancer in epidemiological studies. However, the potential causal association between height and hypothyroidism or thyroid cancer has not been thoroughly explored. Autoimmune thyroid disease (AITD) mainly presents as hypothyroidism, thus we aim to evaluate the causal relationship between height as exposure and its association with AITD or thyroid cancer. Methods: Mendelian randomization (MR) analyses were performed by using genetic instruments associated with height, which were selected from the largest genome-wide association meta-analysis for height in up to 5.4 million individuals. Summary-level data for AITD and thyroid cancer (including 30,234 and 3001 cases, respectively) were collected from the large number of available genome-wide association studies. Bidirectional MR was performed to test for reverse causal association between AITD and adult height. Results: MR analyses showed that increased genetically predicted height was associated with a 4% increased risk of AITD ([CI 1.02 to 1.07], p-value = 1.99E-03) per 1-standard deviation (SD) increase in genetically predicted height. The bidirectional MR did not show any causal association between AITD and adult height. Additionally, increased genetically predicted height was associated with 15% increased risk of thyroid cancer ([CI 1.07 to 1.23], p-value = 2.32E-04) per 1-SD increase in height. Sensitivity analysis confirmed the main results. Conclusions: This MR study showed that 1-SD increase in genetically predicted height was associated with increased risk of AITD and thyroid cancer. In contrast, there was no evidence of a causal association of genetically predicted AITD with height. These results could further aid in investigation of height-related pathways as a means of gaining new mechanistic insights into AITD and thyroid cancer.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Papadopoulou A, Åsvold BO, Burgess S, et al. Height, Autoimmune Thyroid Disease, and Thyroid Cancer: A Mendelian Randomization Study. Thyroid. 2023. PMID: 37772697. doi:10.1089/thy.2023.0272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。